Eyenovia, Inc.
Eyenovia, Inc. (EYEN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EYEN · as of Jun 9, 2026
Key Statistics
Explore Eyenovia, Inc. Data
eyen stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 28.6%
Competitors & Peers
eyen competitorsEYEN
CERC
GRNA
LIANY
LUMO
MGTAStock Performance
Full HistoryAbout Eyenovia, Inc.
Eyenovia, Inc. a New York-based company established in 2014 (originally incorporated as PGP Holdings V, Inc.), functions as a clinical-stage pharmaceutical firm specializing in ophthalmology. The com…
what is eyenovia, inc. · eyen stock overview · eyenovia, inc. company profile · who is eyenovia, inc. ceo · eyen NASDAQ · eyenovia, inc. headquarters · eyenovia, inc. business segments
About Stock Overview & Key Data
Eyenovia, Inc. (EYEN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 25, 2018. As of the latest trading session, EYEN stock price is $7.56, with a market capitalization of $38.6M. The stock has returned -20.75% over the past 12 months and -21.25% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Eyenovia, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Eyenovia, Inc. reported revenue of $813.5M and net income of -$47.0B. For detailed data — including Eyenovia, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eyenovia, Inc. (EYEN) stock price is $7.56. The stock is traded on NASDAQ under the ticker symbol EYEN. The 52-week range is $0.85 – $124.80.